- JP Morgan (JPM) investment banking fees is expected to exceed the stated figure in the Q3
- Johnson & Johnson (JNJ) Innovation Medicine revenue be above the specified amount in Q3
- Johnson & Johnson (JNJ) MedTech revenue be above the specified amount in Q3
- Citigroup (C) provisions for loan losses in the Q3 exceed the stated amount
- Progressive (PGR) combined ratio in Q3
- Will Morgan Stanley's (MS) investment banking revenue be above the specified amount in Q3
- Will Bank of America (BAC) provisions for loan losses in the Q3 be above the specified amount
- Taiwan Semiconductor (TSM) Q3 gross profit margin
- Will Interactive Brokers (IBKR) Q3 net interest income exceed the specified amount